•  
  •  
  •  
  •  

2026-05-24 05:04:13

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Prithvi Exchange India Ltd announces financial performance for the 4th quarter ended March 31, 2026
  • SMS Pharmaceuticals Reports Robust FY26 Performance: PAT Soars 48% and EBITDA Margins Expand to 19%
  • NBCC India Ltd secures 2 orders worth Rs. 42.55 crores
  • Icon Facilitators Limited receives order worth Rs. 2.69 crore
  • Fabtech Technologies Cleanrooms Ltd receives order worth Rs. 65.10 crores

Keywords Selected:  Authorisation

Stock Report

  • CuraTeQ Biologics receives approval for biosimilar Dazublys from UK's MHRA
  • Federal Bank gets authorisation to Collect Government Receipts for the State of Maharashtra via GRAS Portal
  • 'Zaakpay' by MobiKwik gets RBI nod to operate as an Online Payment Aggregator
  • AstraZeneca Pharma India Ltd surrenders marketing authorisation for Olaparib 100mg and 150mg
  • BrePco Biopharma and Piramal Critical Care announce MHRA approval for NeoatriconĀ® in the UK
  • European Commission approves Biocon Biologics' Ustekinumab Biosimilar
  • Infibeam Avenues Ltd Receives RBI's Final Authorisation for Payment Aggregator Licence
  • Venus Remedies achieves Marketing Authorizations for Docetaxel in Israel and Cytarabine in Colombia
  • Venus Remedies consolidates global presence with marketing approvals from Philippines, Saudi Arabia for three drugs
  • Biocon Biologics Receives European Commission Approval for YESAFILI®, Biosimilar Aflibercept
  • Venus Remedies gets marketing approval for cancer drugs from Uzbekistan, Palestine
  • CAMS receives in-principle authorisation to operate as a Payment Aggregator
  • Marksans Pharma Ltd announces UK MHRA approval for Fluoxetine 20mg/5ml Oral Solution
  • ZIM Laboratories Ltd receives Marketing Authorization for Sildenafil 50 mg Orally Dissolving Film in Spain, Europe
  • ZyCoV-DĀ® as a two-dose vaccine receives EUA from DCGI
  • Marksans Pharma announces UK MHRA approval for Bells Healthcare All in One Oral Solution
  • Control Print receives USFDA 510 (k) authorisation for masks
  • Marksans Pharma Limited announces UK MHRA approval for Loperamide 2mg Hard Capsules

Latest Post

  • Prithvi Exchange India Ltd announces financial performance for the 4th quarter ended March 31, 2026
  • SMS Pharmaceuticals Reports Robust FY26 Performance: PAT Soars 48% and EBITDA Margins Expand to 19%
  • NBCC India Ltd secures 2 orders worth Rs. 42.55 crores
  • Icon Facilitators Limited receives order worth Rs. 2.69 crore
  • Fabtech Technologies Cleanrooms Ltd receives order worth Rs. 65.10 crores


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025